Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antonio López Pousa, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Principal Investigator - Francisco Bautista, MD
Hospital Universitario Niño Jesús
Principal Investigator - Jaume Mora, MD
Hospital Sant Joan de Deu
Study Director - Javier Martin Broto, MD
Hospitales Universitarios Virgen del Rocío
Study Director - Javier Martínez Trufero, MD
Hospital Miguel Servet
Principal Investigator - José Antonio López-Martín, MD
Hospital Universitario 12 de Octubre
Principal Investigator - Roberto Díaz, MD
Hospital Universitario La Fe
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- H. Sant Joan de Déu
Barcelona, Spain
- H. de la Santa Creu I Sant Pau
Barcelona, Spain
- H.U. 12 de Octubre
Madrid, Spain
- H.U.Niño Jesús
Madrid, Spain
- H.U. Virgen del Rocío
Seville, Spain
- H.U I Politècnic la Fe
Valencia, Spain
- H.U. Miguel Servet
Zaragoza, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 May 2017
- Primary completion
- 30 Sept 2021
- Completion
- 30 Sept 2021
- Last update posted
- 7 Jun 2022
- Registered enrollment
- 69
- Registry id
- NCT03275818
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.